BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsivkovskii R, Sabet M, Tarazi Z, Griffith DC, Lomovskaya O, Dudley MN. Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solutionfor inhalation) treatment of chronic pulmonary infections. FEMS Immunol Med Microbiol 2011;61:141-6. [DOI: 10.1111/j.1574-695x.2010.00755.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Rojanarat W, Nakpheng T, Thawithong E, Yanyium N, Srichana T. Levofloxacin-proliposomes: opportunities for use in lung tuberculosis. Pharmaceutics 2012;4:385-412. [PMID: 24300299 DOI: 10.3390/pharmaceutics4030385] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
2 Yamaya M, Nishimura H, Hatachi Y, Yasuda H, Deng X, Sasaki T, Mizuta K, Kubo H, Nagatomi R. Levofloxacin inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Antimicrob Agents Chemother 2012;56:4052-61. [PMID: 22585227 DOI: 10.1128/AAC.00259-12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
3 Ibrahim SM, Bin Jumah MN, Othman SI, Alruhaimi RS, Al-Khalawi N, Salama YF, Allam AA, Abukhadra MR. Synthesis of Chitosan/Diatomite Composite as an Advanced Delivery System for Ibuprofen Drug; Equilibrium Studies and the Release Profile. ACS Omega 2021;6:13406-16. [PMID: 34056488 DOI: 10.1021/acsomega.1c01514] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Ann Am Thorac Soc 2014;11:1120-9. [PMID: 25102221 DOI: 10.1513/AnnalsATS.201402-050AS] [Cited by in Crossref: 111] [Cited by in F6Publishing: 57] [Article Influence: 15.9] [Reference Citation Analysis]
5 Sheikh Z, Ong HX, Pozzoli M, Young PM, Traini D. Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment? Expert Opinion on Orphan Drugs 2017;6:69-84. [DOI: 10.1080/21678707.2018.1409110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Anderson S, Atkins P, Bäckman P, Cipolla D, Clark A, Daviskas E, Disse B, Entcheva-Dimitrov P, Fuller R, Gonda I, Lundbäck H, Olsson B, Weers J. Inhaled Medicines: Past, Present, and Future. Pharmacol Rev 2022;74:48-118. [PMID: 34987088 DOI: 10.1124/pharmrev.120.000108] [Reference Citation Analysis]
7 Nickel JC, Shoskes DA, Wagenlehner FM. Management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): the studies, the evidence, and the impact. World J Urol. 2013;31:747-753. [PMID: 23568442 DOI: 10.1007/s00345-013-1062-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
8 Zarogoulidis P, Kioumis I, Porpodis K, Spyratos D, Tsakiridis K, Huang H, Li Q, Turner JF, Browning R, Hohenforst-Schmidt W, Zarogoulidis K. Clinical experimentation with aerosol antibiotics: current and future methods of administration. Drug Des Devel Ther 2013;7:1115-34. [PMID: 24115836 DOI: 10.2147/DDDT.S51303] [Cited by in Crossref: 10] [Cited by in F6Publishing: 34] [Article Influence: 1.1] [Reference Citation Analysis]
9 Shiratori B, Zhang J, Usami O, Chagan-Yasutan H, Suzuki Y, Nakajima C, Uede T, Hattori T. Quinolone-induced upregulation of osteopontin gene promoter activity in human lung epithelial cell line A549. Antimicrob Agents Chemother 2012;56:2868-72. [PMID: 22430970 DOI: 10.1128/AAC.06062-11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]